Micro SaaS / API Wrapper / Bot
Retirement Decumulation Intelligence Engine
A $15/month consumer-facing retirement spend-down platform that applies dynamic withdrawal guardrails, models Social Security claiming scenarios, tracks healthcare cost inflation separately, and sends a monthly safe-to-spend number, giving DIY retirees access to logic previously locked inside advisor-only tools.
Research Stage Progress
Demand side (strong): 72M+ US adults aged 55-74 in the target band; 11,200/day turning 65 through 2027; $49.1T total US retirement assets at end-2025; 62% of adults 50+ never used a financial advisor; Boldin's 88,087 paid subscribers at $144/yr prove the consumer willingness to pay. Morningstar safe withdrawal rate debates (3.7% in 2024, 3.9% in 2026) are generating sustained high-intent search traffic. FPA Journal named sequence-of-returns risk the #1 retirement threat in June 2026. Healthcare inflation at 5.8% vs. 2.4% SS COLA is actively breaking plans built in 2023-2024.
Competition side (favorable gap): No sub-$20/month consumer tool combines all five capabilities: dynamic withdrawal guardrails + joint SS optimization + healthcare inflation modeling + sequence-risk alerting + monthly safe-to-spend number. The gap is real and documented. Boldin is the most likely to close it but is estimated 18-24 months away from feature parity. Income Lab validates the feature set works at $199-$299/mo advisor pricing.
Score capped at 7.8 (not higher) because: Boldin's 88K subscriber base and VC backing give it strong resources to close the feature gap faster than expected; T. Rowe Price's SS Optimizer expansion path is a second credible threat; the precise sub-segment that needs all five capabilities (vs. just better Monte Carlo) is a meaningful but bounded slice of the 72M-adult TAM.
Score rationale (0-10 scale):
Why 6.8 and not higher: Two high-rated risks keep the score below 7.0. First, Boldin has 88K paying subscribers and estimated ~$20M in funding; its 18-24 month window to feature parity is the binding constraint on this opportunity, and that window is already ticking. Second, T. Rowe Price's SS Optimizer (launched March 2024, expanded to advisors March 2025) represents a plausible path to a free, institutionally-backed full decumulation tool that a small team cannot outcompete on distribution.
Why 6.8 and not lower: The product is technically buildable by one developer in 3-6 months with no regulatory licensing costs. Unit economics are sound at conservative inputs: $550 LTV vs. $55 blended CAC gives a 10x ratio and 4-month payback. The feature gap at the consumer price point is documented and currently unoccupied. The SEO content channel builds audience before a competitor ships features. The demographic driver (4.1M turning 65 in 2024, 11K/day through 2027) is structural.
Biggest killer: Execution speed relative to Boldin. Not regulatory risk, not technical complexity.
Lane 49: Retirement Decumulation Intelligence Engine
One-liner
A $15/month consumer-facing retirement spend-down platform that applies dynamic withdrawal guardrails (risk-based, not static 4%), models Social Security claiming scenarios, tracks healthcare cost inflation separately, and sends a monthly "safe-to-spend" number — giving DIY retirees access to logic previously locked inside advisor-only tools.
Discovery method
Trend Sniffer + Pain-point Extractor + Idea Generator
Trend signal: The decumulation gap is a documented industry problem in 2025-2026. Vanguard's 2025 annual report explicitly calls it out. The Social Security Optimization Tool market alone is $356M in 2025, growing at 11.2% CAGR to $912M by 2034 (Intel Market Research). Morningstar revised its safe withdrawal rate in December 2025 to 3.9%, reigniting public debate. Over 10,000 Americans turn 65 daily, and the "peak 65" cohort of 4.1 million Americans hit retirement age in 2024. Every one of them faces the decumulation problem.
Pain-point signal (tools): Income Lab is the #1 rated decumulation tool per T3/Inside Information 2025 survey — but it is advisor-only. MaximizeMySSA costs $40/year but does only Social Security, no cash-flow integration. Boldin ($12/month) uses a largely static framework and lacks dynamic guardrails or sequence-risk alerts. RetirePlan (App Store) has documented missing features: no RMD planning for different-aged spouses. Empower Retirement (Trustpilot) complaints: outdated technology, missing modern features. The gap is clear: advisor-quality decumulation logic is locked behind institutional pricing; consumer tools are static.
Pain-point signal (risk): FPA Journal (June 2026): "Sequence-of-returns risk is the most acute and least understood danger of the decumulation phase." Healthcare inflation at 5.8% vs. 2.4% SS COLA means most existing retirement projections built in 2023-2024 are materially optimistic. No consumer tool alerts a retiree when their portfolio has crossed a guardrail threshold that warrants spending cuts.
Idea: A $15/month tool targeted at the 55-70-year-old self-directed retiree that does five things static tools cannot: (1) applies dynamic withdrawal guardrails, recalculating sustainable monthly spend from actual portfolio value quarterly; (2) models joint SS claiming scenarios across filing ages 62-70; (3) models healthcare cost as a separate inflation line item at 5.8%; (4) sends a sequence-risk alert when the portfolio drops below a configurable guardrail; (5) produces a monthly "safe-to-spend" number the user can actually act on.
Opportunity narrative
The demand
The US retiree-and-near-retiree population is the largest it has ever been. 4.1 million Americans turned 65 in 2024. Over 10,000 per day through the late 2020s. This is a well-documented, structurally growing market.
But the demand for decumulation tools — as distinct from accumulation — is underserved by consumer software. Income Lab (the professional benchmark) is advisor-only. Boldin at $12/month is the leading consumer tool but relies on static 4% rule logic and has no dynamic guardrail engine. Morningstar's own research shows dynamic strategies produce 30% more retirement income than static approaches — yet no sub-$20/month consumer tool implements them.
Social Security alone is a huge source of confusion. A married couple retiring at 65 can claim benefits in ways that range from $200,000 to $400,000+ in lifetime benefit depending on filing sequence. Yet MaximizeMySSA ($40/year) is the only standalone consumer tool, with a text-only interface and no cash-flow integration.
The gap
The market split is stark:
- Advisor-only tools (Income Lab, Covisum, LifeYield): full-featured, $thousands/year, inaccessible to self-directed retirees
- Consumer-facing tools (Boldin, ProjectionLab, FIRECalc): affordable but static, lacking dynamic guardrails, real-time sequence-risk alerts, or integrated SS optimization
The $15-20/month price band for a consumer tool with advisor-quality decumulation logic has no occupant.
The product concept
- Monthly "safe-to-spend" calculation: takes current portfolio balance, applies user's chosen withdrawal strategy (4% static / Guyton-Klinger guardrails / variable percentage withdrawal / RMD-based), outputs a monthly dollar figure
- Quarterly portfolio rebalance: recalculates safe-to-spend after each quarter; flags if guardrail is crossed (e.g., portfolio down 15% from initial value = reduce spending trigger)
- Social Security optimizer: models filing-age scenarios for individual and spouse (ages 62-70); shows cumulative lifetime benefit by scenario; neutral tool, no "recommendation" — user picks their scenario
- Healthcare cost module: separate inflation line item at user-configurable rate (default 5.8%); projects out-of-pocket Medicare costs, LTC reserve target, IRMAA thresholds
- Sequence-risk meter: shows probability of portfolio survival to age 90/95 based on Monte Carlo (500 simulations); turns amber/red when sequence-risk threshold is crossed
- Account linking: read-only Plaid (US) for live portfolio balance
- Mobile-first dashboard; monthly email digest
Revenue model
- $15/month (or $120/year) — positioned between Boldin ($12) and advisor-engagement products ($200+)
- Freemium: SS claiming calculator free (acquisition hook for people searching "social security calculator when to claim")
- Paid: dynamic guardrails, healthcare module, sequence-risk meter, monthly safe-to-spend number, account linking
- SEO: "retirement withdrawal calculator," "social security claiming strategy," "sequence of returns risk tool," "4% rule alternative" — high-volume, high-intent queries
- Content marketing: "Is the 4% rule dead?" type articles target debate-driven search traffic
Why now
- "Peak 65" US retirement wave: 4.1 million Americans turned 65 in 2024; the cohort stays large through the late 2020s
- Morningstar revised the safe withdrawal rate in December 2025 — this event created high-intent search traffic for alternatives
- Income Lab added SS optimization in June 2025 — the advisor market validation is there; consumer market has not caught up
- Healthcare inflation (5.8%) has diverged materially from general inflation — existing static plans are breaking
- TCJA permanence (One Big Beautiful Bill Act 2025) stabilizes the tax layer; SS law unchanged — projections are stable enough for consumer tools
Red line / compliance
- Jurisdiction: US primary; UK (pension drawdown, State Pension claiming) and AU (superannuation drawdown) as secondary later
- Not financial advice: all outputs carry "These projections are illustrative estimates only. This tool does not constitute financial advice. Social Security projections are based on current law, which may change."
- No specific product recommendations (no annuity, insurance, or fund recommendations)
- IRMAA and Medicare cost estimates must be flagged as estimates based on current law
- No advisory registration required in the US for a calculator tool with clear disclaimers and no execution capability
7-dimension triage scores
| Dimension | Score (0-5) | Rationale |
|---|---|---|
| Demand pull | 5 | 4.1M Americans turned 65 in 2024; 10K/day ongoing; documented decumulation tool gap; active public debate about safe withdrawal rates in 2025-2026 |
| Acquisition feasibility | 4 | High-intent SEO (4% rule, SS claiming, sequence risk); FIRE community referral; content marketing on SWR debate; YouTube retirement channels are a strong channel |
| Agent advantage | 4 | Monte Carlo engine + quarterly recalculation + SS claiming optimization is genuinely automated and defensible; advisor-quality logic delivered at $15/month is the structural advantage |
| Low-volume economics | 4 | $15/month; at 500 users = $7,500 MRR = $90K ARR; Plaid account link ~$0.30/account; Monte Carlo compute is trivial; support costs are the main variable |
| Operator hand lightness | 4 | Monthly calculations are automated; SS law changes require periodic manual updates; healthcare inflation rate needs annual review; otherwise low-touch |
| Market trend | 5 | "Peak 65" demographic wave is structural; SS market growing 11.2% CAGR to 2034; decumulation identified as #1 priority by 300+ retirement industry experts (ASPPA Nov 2025 survey) |
| Policy red line | 4 | Disclaimer-carrying calculator is legal; SS law changes are a material risk (any SS reform could require tool updates); IRMAA thresholds change annually; Medicare law changes add update overhead; risk is maintenance burden, not regulatory shutdown |
Triage total: 30 / 35
Evidence in assets/
assets/demand_evidence.md— industry reports, market size data, tool gap analysis, baby boomer demographic data, Morningstar/FPA sourcesassets/competitor_snapshot.md— feature comparison table: advisor-only tools vs. consumer tools; gap matrix
Hypotheses for downstream research
- What is the actual size of the self-directed US retiree segment that would pay $15/month vs. the segment that only uses free tools?
- How complex is implementing Guyton-Klinger guardrails vs. VPW in a consumer-facing SaaS — could one developer build it in < 4 months?
- What is the SEO competition intensity on "retirement withdrawal calculator" and "social security claiming tool"?
- Is UK State Pension + drawdown a viable near-term expansion (FCA implications for a projection tool)?
Competitor leads for research
- Income Lab (incomelaboratory.com) — advisor-only benchmark; pricing and feature set to compare against
- Boldin (boldin.com) — closest consumer competitor
- MaximizeMySSA (maximizemysocialsecurity.com) — SS optimization standalone
- ActuaPlan — Monte Carlo first tool with healthcare and longevity
- T. Rowe Price SS Optimizer (launched 2024) — institution-backed consumer tool